Brace Pharma Capital
VC
INVESTOR TYPE
Active
STATUS
6
PROFESSIONALS
19
INVESTMENTS
12
PORTFOLIO
3
EXITS
Description
Brace Pharma Capital is a strategic investment firm based in Rockville, Maryland. The firm seeks to invest in innovative, life-changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options. It was founded in 2013 with an additional office in Boston, Massachusetts.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2013
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 155 Gibbs Street
- Suite 406
- Rockville, MD 20850
- United States
+1 (240) 000-0000
Brace Pharma Capital Investments (19)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| ReViral | 01-Aug-2018 | Early Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 2 | |
| 000000 00000000000 | 10-Jul-2018 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 1 | 0000000 0000000 |
| 000000000 00000000 | 26-Jun-2018 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | |
| 0000000 | 02-Feb-2018 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 2 | |
| 000000 00000000000 | 24-Jan-2018 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 1 | 0000000 0000000 |
| 0000000 0000000000 | 13-Feb-2017 | 0000 | 000.00 | Biotechnology | Profitable | |
| 0000000 0000000000 | 05-Jan-2017 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 0000 00000 |
| 0000000 0000000000 | 31-Oct-2016 | 00000 00000 | 0000 | Biotechnology | Profitable | |
| F2G | 20-Jun-2016 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 | |
| Zymeworks | 08-Jan-2016 | Mezzanine | 000.00 | Biotechnology | Profitable |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Brace Pharma Capital’s full profile, request a free trial.
Brace Pharma Capital Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Avrobio | 21-Jun-2018 | IPO | 00000 | Completed |
|
| 0000 000000000000 | 29-Mar-2018 | 000 | 000.00 | Completed |
|
| 000000000 | 28-Apr-2017 | 000 | 0000 | Completed |
|
Brace Pharma Capital Team (12)
You’re viewing 5 of 12 team members. Get the full list »Brace Pharma Capital Co-Investors (71)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Atlas Venture | 4 | 0 | 0 |
| Alexandria Venture Investments | 0 | 0 | |
| F-Prime Capital Partners | 0 | 0 | 0 |
| Novo Holdings | 0 | 0 | 0 |
| Amgen Ventures | 0 |